Tangling with the board of Teva Pharmaceutical Industries Ltd. cost Chief Executive Jeremy Levin his job on Wednesday, as the world's largest generic drug maker searches for a solution to competition for its top-selling product and from Indian upstarts.

Teva said Dr. Levin will leave the company right away, after less than a year and a half at the drug maker's helm.